Market Tracker

04/17 8:50am ET

Hyperion Therapeutics Inc (NASDAQ:HPTX)

24.97
Data as of Apr 16
 +0.37 / +1.50%
Today’s Change
15.92
Today|||52-Week Range
32.98
+23.49%
Year-to-Date
No recent news for Hyperion Therapeutics Inc.

Today’s Trading

Previous close24.60
Today’s open24.43
Day’s range-- - --
Volume41,104
Average volume (3 months)99,654
Market cap$505.3M
Dividend yield--
Data as of 04/16/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-61.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio12.2
Price/Sales9.30
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
KMDAKamada Ltd+0.22+1.60%
BLUEbluebird bio Inc-0.73-3.60%
ENZYEnzymotec Ltd+0.02+0.10%
CGENCompugen Ltd-0.03-0.33%
Data as of 04/16/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)$0.02
Annual revenue (last year)$42.2M
Annual profit (last year)$16.6M
Net profit margin39.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer, Secretary &
Senior VP
Jeffrey S. Farrow
Corporate headquarters
South San Francisco, California

Forecasts